Sort
16,300 grants matching “fatty liver disease”
In Vivo 2H/13C Metabolic Flux Analysis of NASH Pathogenesis
$347,358Jamey D. Young · Vanderbilt University · R01 · FY2018 · DK
In Vivo 2H/13C Metabolic Flux Analysis of NASH Pathogenesis
$347,358Jamey D. Young · Vanderbilt University · R01 · FY2017 · DK
In Vivo 2H/13C Metabolic Flux Analysis of NASH Pathogenesis
$347,358Jamey D. Young · Vanderbilt University · R01 · FY2019 · DK
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
$347,319Zhaoli Sun · Johns Hopkins University · U01 · FY2014 · AA
Cells Processing High Density Lipoproteins
$347,250Salman Azhar · Palo Alto Veterans Instit For Research · R56 · FY2015 · HL
Tissue-specific Mechanism of Action of the Metabolic Hormones FGF19 and FGF21
$347,225Steven A Kliewer · Ut Southwestern Medical Center · R01 · FY2015 · DK
Magnetic Resonance Study of Chemotherapy-induced Liver Toxicity
$347,197Kristen L Zakian · Sloan-Kettering Inst Can Research · R21 · FY2008 · CA
Image Guided Robotic Nephron-Sparing Surgery
$347,103Robert James Webster · Vanderbilt University · R01 · FY2017 · EB
De novo lipogenesis in the pathogenesis of non-alcoholic fatty liver disease
$347,102Jean-Marc Schwarz · Touro University Of California · R01 · FY2008 · DK
Targeting Lipid Metabolism in Colorectal Cancer
$347,063Yekaterina Zaytseva · University Of Kentucky · R01 · FY2021 · CA
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
$346,995Andrew Patterson · Pennsylvania State University, The · R01 · FY2017 · ES
Image Guided Robotic Nephron-Sparing Surgery
$346,981Robert James Webster · Vanderbilt University · R01 · FY2018 · EB
Magnetic Resonance Study of Chemotherapy-induced Liver Toxicity
$346,968Kristen L Zakian · Sloan-Kettering Inst Can Research · R21 · FY2009 · CA
Molecular mechanisms of yeast PAS kinase regulation and function.
$346,949Julianne H. Grose · Brigham Young University · R15 · FY2012 · GM
Targeting Lipid Metabolism in Colorectal Cancer
$346,916Yekaterina Zaytseva · University Of Kentucky · R01 · FY2022 · CA
Circadian regulation of lipid metabolism
$346,913M Mahmood Hussain · Suny Downstate Medical Center · R01 · FY2012 · DK
Targeting ASK1 as a novel therapy to treat biliary atresia
$346,910Neil McDonnell · Seal Rock Therapeutics, Inc. · R41 · FY2025 · DK
Project 1: Mechanisms of Stiffening in Liver Cancer
$346,854Dennis E. Discher · University Of Pennsylvania · U54 · FY2017 · CA
NASH PROJECT
$346,835Case Western Reserve University · U01 · FY2003 · DK
NASH PROJECT
$346,835Case Western Reserve University · U01 · FY2002 · DK
A genomics-based strategy to precision phenotyping and drug repositioning in cardiometabolic diseases
$346,830Marijana Vujkovic · University Of Pennsylvania · R01 · FY2024 · DK
Guanylyl cyclase receptors: Targets for medical intervention
$346,815Joseph P Albanesi · Ut Southwestern Medical Center · R01 · FY2009 · DK
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
$346,752Rima F Kaddurah-Daouk · Duke University · U01 · FY2022 · AG
Hepatic Insulin Resistance Following Hemorrhage
$346,695Joseph Louis Messina · University Of Alabama At Birmingham · R01 · FY2008 · DK
Environmental Ah Receptor Ligand Impact on the Host-Microbiome Metabolic Axis
$346,675Andrew Patterson · Pennsylvania State University, The · R01 · FY2018 · ES